Join us for a ground-breaking and insightful forum on inhaled and nasal biologics development: Two days of cutting-edge talks and networking opportunities with leaders in this complex area of inhaled medication and inhaled vaccine development.
3rd Annual Inhaled & Nasal Biologics/DNA Forum
26-27th September 2024 | Cambridge, UK
We are delighted to announce that we are hosting the 3rd edition of the Annual Inhaled and Nasal Biologics/DNA Forum in September 2024. We invite you to join two days of cutting-edge talks and networking opportunities with leaders in this complex area of drug product development.
Biologics and nucleotide-based therapeutics have gained increasing importance in the last decade. Pulmonary and intranasal delivery of these presents a compelling, non-invasive alternative to traditional parenteral methods, offering potential for both local respiratory and systemic treatments across a variety of diseases and indications. However, biologics, mRNA, nucleotide-based therapeutics and vaccines present unique challenges for respiratory administration and whilst there can be many ways to design a product, the developer needs to balance, amongst many other things, product performance, manufacturability, regulatory risk, and commercial elements.
During this 3rd edition, the conference promises to provide a platform for discussing the latest research and optimal strategies for pulmonary and intranasal biologic/DNA drug development. With renowned industry leaders who will share their insight and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don't miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
We are excited to announce that we will be releasing news of our esteemed speakers over the coming weeks. Be sure to bookmark this page and follow us on LinkedIn to stay updated with the latest developments.
Secure your place today - registration is live.
KEYNOTE SPEAKER: Dr Jenny Lam, Associate Professor in Pharmaceutics at the UCL School of Pharmacy
We are pleased to announce that Dr Jenny Lam, Associate Professor in Pharmaceutics at the UCL School of Pharmacy, will be the keynote speaker for the third Annual Inhaled and Nasal Biologics/DNA Forum 2024.
Dr Jenny Lam is a leading expert in novel respiratory delivery systems at the UCL School of Pharmacy, one of the world’s leading pharmacy schools. Dr Lam will present on the theme of ‘Alternative to LNPs – development of peptide-based RNA delivery systems for pulmonary delivery’, setting the stage for thought-provoking exchanges throughout this groundbreaking industry event.
AGENDA
Wednesday, September 25th 2024 - Networking
Intertek Laboratory Tour (optional), Intertek Melbourn, Cambridgeshire, 2 pm
Networking drinks reception, Hinxton Hall, 5.30 pm
Thursday, 26th September 2024 - Day 1 of Conference
Conference Session & Panel Discussion
Networking Drinks 5:30 pm & Evening: Conference Dinner
Friday, 27th September 2024 - Day 2 of Conference
Conference Session & Panel Discussion
REGISTRATION
The registration fee per attendee is shown below. This includes the conference registration, accommodation at Hinxton Hall if required, the conference dinner and networking drinks.
Rate | Incl. 2 nights' accommodation | Incl. 1 night accommodation | No accommodation required |
Early Bird Rate (until 31 May 2024) | £499 | £449 | £399 |
Standard Rate (from 1 June 2024) | £549 | £499 | £449 |
LOCATION
Set within a one-hundred-acre estate bordering the River Cam, Hinxton Hall Conference Centre is located on the Wellcome Genome Campus, alongside research institutions that are at the forefront of the genomics revolution.
Hinxton Hall is 25 minutes from the centre of Cambridge, and a mere 60 minutes from London and accessible from Heathrow, Luton and Gatwick airports and is only 20 minutes from London Stansted Airport. The hall is easily accessible from the M11. For GPS please use: CB10 1SA.
The Intertek team will book accommodation on your behalf if you indicate that you require a room during registration.
QUESTIONS? Please contact us:
T: UK +44 (0)1763 261 648 | E: inhaled.biologics@intertek.com